Initially described as an exhaustion marker, the expression of PD-1 on CD8+ T cells is now reported as a strong predictor of the response to ICB in NSCLC and correlated with increased overall survival [38]. The gene discussed is PDCD1; the disease is non-small cell lung carcinoma.